1

SIMPLY OYAVAS®
AN ANTI-VEGF MONOCLONAL ANTIBODY

SIMPLY CONVINCING

Similar efficacy, safety and quality to the reference product

 

Indicated for the treatment of the same cancer types as the reference product

*2

* † 1,3

SIMPLY DEDICATED

Over 20 years of experience in biosimilars

SIMPLY RELIABLE

Manufactured in Spain

2

VEGF, vascular endothelial growth factor *Avastin® †Not all treatment schedules within each cancer type are approved due to patent protection   ‡STADA founded Bioceuticals Arzneimittel AG in 2000 1. Oyavas® SmPC (Apr. 2021). 2. Oyavas® EPAR Public Assessment Report. Available at: https://www.ema.europa.eu/en/documents/ assessment-report/oyavas-epar-public-assessment-report_en.pdf. Last accessed May 2021. 3. Avastin® SmPC (Feb. 2021).

SIMPLY CONVINCING
OYAVAS
® HAS SIMILAR EFFICACY AND SAFETY TO THE REFERENCE PRODUCT *

1

*Avastin®   1. Results from the STELLA study: Trukhin D, et al. BioDrugs 2021. Available at: https://doi.org/10.1007/s40259-021-00483-w. Last accessed May 2021. Oyavas® EPAR Public Assessment Report. Available at: https://www.ema.europa.eu/en/documents/assessment-report/oyavas-epar-public-assessment-report_en.pdf. Last accessed May 2021.  CI, confidence interval 

†Patients with newly diagnosed/recurrent non-squamous NSCLC (non-small cell lung cancer), stage IIIb/IV 

SIMPLY DEDICATED
CLONMEL HEALTHCARE IS A MEMBER OF THE STADA GROUP

CARING FOR PEOPLE'S HEALTH AS A TRUSTED PARTNER

We have been manufacturing

and distributing pharmaceuticals

for more than 125 years


Long-standing history in serving

patients and physicians with high-quality pharmaceutical products


Safety is our priority: we ensure

that the safety and efficacy of our

products are never compromised

MAKING EFFECTIVE MEDICINE ACCESSIBLE

Over 20 years of experience in
biosimilars*

Building on the innovation of biologics, providing lower-priced
alternatives to the reference
products

Making biologics available to more patients for more than ten years
 

*STADA founded Bioceuticals Arzneimittel AG in 2000

SIMPLY RELIABLE
OYAVAS® IS MANUFACTURED IN THE EU 

1

All manufacturing steps take place in Spain for a strong and reliable EU supply chain
oyavas_icon_Map_RGB.png

1. Oyavas® EPAR Public Assessment Report. Available at: https://www.ema.europa.eu/en/documents/assessment-report/oyavas-epar-public-assessment-report_en.pdf. Last accessed May 2021.